Thoughts on fund compensation of adverse events following immunization in China
10.19428/j.cnki.sjpm.2022.21653
- VernacularTitle:疑似预防接种异常反应的基金补偿模式的思考
- Author:
Ting SU
1
;
Zhilei ZHONG
1
;
Dan YOU
1
;
Litao RUAN
1
;
Shengran YANG
1
;
Qian LI
1
;
Qiuyu CHEN
1
;
Zexu YU
1
;
Cheng LI
2
Author Information
1. Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, Yunnan 650118, China
2. School of Journalism and Communication, Shanghai International Studies University, Shanghai 200083, China
- Publication Type:Journal Article
- Keywords:
vaccine;
fund;
compensation;
adverse events following immunization
- From:
Shanghai Journal of Preventive Medicine
2022;34(4):382-387
- CountryChina
- Language:Chinese
-
Abstract:
After the promulgation and implementation of the Vaccine Administration Law of the People’s Republic of China， the compensation of suspected adverse reactions in China is to be reformed and innovated. There have been attempts at compensation through government finance and insurance， but there has been no precedent for a fund of vaccine-related compensation in China， which means that this could be a new method of solving disputes of compensation for vaccine-related incidences and enhancing public confidence in vaccination. It is suggested that under the current system， we can select a province as a pilot to explore the fund compensation mechanism. The fund comes from special financial allocation， special taxation of vaccine enterprises， fund investment income， charitable donation and other channels. Through a special fund management organization， the independent identification and compensation process can be realized， so as to shorten the current compensation procedure， improve the amount of compensation， ultimately protect the interests of all parties， and promote the steady development of vaccination.
